The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles

China Medical University Hospital2 个研究点分布在 1 个国家开始时间: 2006年4月21日最近更新: 2006年11月7日

适应症

试验速览

The purpose of this study is to determine whether the Lipid-lowing Tea is effective and safe in the treatment of Hyperlipidemia Patients

•Patient aged 20-65 years;either sex
•Patient diagnosed with hyperlipidemia(fasting levels of TC>=200mg/dL),or TG>=200mg/dL but <400mg/dL,or LDL-C>=130mg/dL)
•Patient who has signed the informed consent form

•Patient with pregnancy (or child bearing potential),or in lactation
•Patient with any lipid regulating agents within 4 weeks prior to study period
•Patient currently taking concomitant medications, such as oral contraceptives, or any medical treatment capable of interfering with lipid metabolism(eg thiazides, β-blockers, cyclosporins, itraconazole erythromycin,and danazol)
•Patient with medical history of hypothyroidism, pancreatitis, cholestasis, nephrotic syndrome, gall bladder disease, primary biliary cirrhosis.
•Patient with liver dysfunction (SGOT or SGPT>2x ULN)
•Patient with renal insufficiency (serum creatinine>1.3mg/dL)
•Patient with myocardial infarction,cerebrovascular disease,or major operations within 6 months prior to the study period.

发起方

申办方类型

Other

Loading locations...